Royal Bank of Canada Cuts Prothena (NASDAQ:PRTA) Price Target to $36.00
Prothena (NASDAQ:PRTA – Free Report) had its price target reduced by Royal Bank of Canada from $43.00 to $36.00 in a research report released on Thursday, Benzinga reports. They currently have a sector perform rating on the biotechnology company’s stock. A number of other analysts have also issued reports on the stock. Cantor Fitzgerald lowered […]
More Stories
Jane Street Group LLC Has $508,000 Position in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT)
Jane Street Group LLC cut its position in shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Free Report) by 77.4% during...
Costco Earnings Top Estimates as Giant Retailer Navigates Tariffs
By Wesley Brown Costco Wholesale Corp. posted strong fiscal third-quarter results on May 29, stating that it is navigating the...
Trump to Hold Press Conference With Musk on His Last Day as DOGE Chief
By Joseph Lord President Donald Trump announced on May 29 that he would hold a press conference the next day...
Vident Advisory LLC Takes Position in Voya Financial, Inc. (NYSE:VOYA)
Vident Advisory LLC bought a new stake in Voya Financial, Inc. (NYSE:VOYA – Free Report) in the 4th quarter, according...
Are Modular Sofas Worth It? Find out here…
Modular sofas offer a lot of flexibility when compared to a traditional sofa, but are they really worth the hype?...
Vistra Corp. (NYSE:VST) Shares Sold by Two Sigma Investments LP
Two Sigma Investments LP lowered its holdings in Vistra Corp. (NYSE:VST – Free Report) by 97.8% in the fourth quarter,...